Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2004;31(2):157-9.

First clinical use of the redesigned HeartMate II left ventricular assist system in the United States: a case report

Affiliations
Case Reports

First clinical use of the redesigned HeartMate II left ventricular assist system in the United States: a case report

O H Frazier et al. Tex Heart Inst J. 2004.

Erratum in

  • Tex Heart Inst J. 2004;31(3):333

Abstract

Axial flow ventricular assist devices show great promise as a potential treatment for patients with end-stage heart failure. The HeartMate II system, redesigned on the basis of initial clinical experiences in Europe, is now in clinical trials in the United States. We report on the 1st use of the newly redesigned HeartMate II in the United States. The system has unique features, which include an accurate flow estimator and the ability to automatically detect and correct excessive left ventricular unloading. The new design also incorporates changes in the texturing of the blood-contacting surfaces to prevent thrombosis. The implantation technique and configuration are similar to those of the HeartMate XVE LVAS and require a median sternotomy for access. The 1st patient to receive the device in the United States has had an uncomplicated perioperative course and now awaits transplantation.

PubMed Disclaimer

Figures

None
Fig. 1 HeartMate® II left ventricular assist device.
None
Fig. 2 Regions of the HeartMate II that were previously textured.
None
Fig. 3 Radiograph showing the redesigned HeartMate II in place in the 1st patient in the United States to have the device implanted.

References

    1. Frazier OH, Myers TJ, Westaby S, Gregoric ID. Clinical experience with an implantable, intracardiac, continuous flow circulatory support device: physiologic implications and their relationship to patient selection. Ann Thorac Surg 2004;77:133–42. - PubMed
    1. Noon GP, Morley DL, Irwin S, Abdelsayed SV, Benkowski RJ, Lynch BE. Clinical experience with the MicroMed DeBakey ventricular assist device. Ann Thorac Surg 2001;71(3 Suppl):S133–8. - PubMed
    1. Griffith BP, Kormos RL, Borovetz HS, Litwak K, Antaki JF, Poirier VL, Butler KC. HeartMate II left ventricular assist system: from concept to first clinical use. Ann Thorac Surg 2001;71(3 Suppl):S116–20. - PubMed
    1. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001;345:1435–43. - PubMed

Publication types